Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Effect of Febuxostat on Blood Pressure

ClinicalTrials.gov ID: NCT01496469

Public ClinicalTrials.gov record NCT01496469. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-Blind, Placebo-Controlled Study to Assess the Effect of Febuxostat 80 mg Once Daily Compared to Placebo on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension

Study identification

NCT ID
NCT01496469
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
121 participants

Conditions and interventions

Conditions

Interventions

  • Febuxostat Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2012
Primary completion
Jul 31, 2014
Completion
Jul 31, 2014
Last update posted
Aug 30, 2015

2012 – 2014

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
45
Facility City State ZIP Site status
Not listed Foley Alabama
Not listed Buena Park California
Not listed Carmichael California
Not listed Fresno California
Not listed Irvine California
Not listed Lomita California
Not listed Paramount California
Not listed Sacramento California
Not listed San Diego California
Not listed Wildomar California
Not listed Milford Connecticut
Not listed Fort Lauderdale Florida
Not listed Miami Florida
Not listed Tallahassee Florida
Not listed Tampa Florida
Not listed Dunwoody Georgia
Not listed Roswell Georgia
Not listed Suwanee Georgia
Not listed Avon Indiana
Not listed Indianapolis Indiana
Not listed Lexington Kentucky
Not listed Biddeford Maine
Not listed City of Saint Peters Missouri
Not listed St Louis Missouri
Not listed Henderson Nevada
Not listed Las Vegas Nevada
Not listed Albuquerque New Mexico
Not listed Glens Falls New York
Not listed Greensboro North Carolina
Not listed Salisbury North Carolina
Not listed Shelby North Carolina
Not listed Fargo North Dakota
Not listed Cincinnati Ohio
Not listed Columbus Ohio
Not listed Lyndhurst Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Tipton Pennsylvania
Not listed Carrollton Texas
Not listed Dallas Texas
Not listed San Antonio Texas
Not listed Burke Virginia
Not listed Manassas Virginia
Not listed Port Orchard Washington
Not listed Madison Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01496469, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 30, 2015 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01496469 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →